Professional Documents
Culture Documents
Ebook Mathematical Computational and Experimental T Cell Immunology Carmen Molina Paris Editor Online PDF All Chapter
Ebook Mathematical Computational and Experimental T Cell Immunology Carmen Molina Paris Editor Online PDF All Chapter
Ebook Mathematical Computational and Experimental T Cell Immunology Carmen Molina Paris Editor Online PDF All Chapter
https://ebookmeta.com/product/current-problems-in-experimental-
and-computational-engineering/
https://ebookmeta.com/product/theoretical-and-computational-
physics-of-gas-discharge-phenomena-a-mathematical-introduction-
sergey-t-surzhikov/
https://ebookmeta.com/product/genedis-2022-computational-biology-
and-bioinformatics-advances-in-experimental-medicine-and-
biology-1424-panagiotis-vlamos-editor/
https://ebookmeta.com/product/computational-and-experimental-
simulations-in-engineering-proceedings-of-
icces-2023%e2%80%95volume-1-1st-edition-shaofan-li/
https://ebookmeta.com/product/a-mathematical-modeling-framework-
to-simulate-and-analyze-cell-type-transitions-1st-edition-
daniella-schittler/
https://ebookmeta.com/product/analysis-of-legal-argumentation-
documents-a-computational-argumentation-approach-translational-
systems-sciences-29-hayato-hirata/
https://ebookmeta.com/product/mathematical-computational-
intelligence-and-engineering-approaches-for-tourism-agriculture-
and-healthcare-1st-edition-pankaj-srivastava/
Carmen Molina-París
Grant Lythe Editors
Mathematical,
Computational
and Experimental
T Cell Immunology
Mathematical, Computational and Experimental
T Cell Immunology
Carmen Molina-París • Grant Lythe
Editors
Mathematical,
Computational and
Experimental T Cell
Immunology
Editors
Carmen Molina-París Grant Lythe
Department of Applied Mathematics, Department of Applied Mathematics,
School of Mathematics School of Mathematics
University of Leeds University of Leeds
Leeds, UK Leeds, UK
This Springer imprint is published by the registered company Springer Nature Switzerland AG
The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
to Federico-ico and Sofía-pía,
may they always be good, happy and free.
Stimulation of naive CD4+ T cells with PMA and Ionomycin.
Naive CD4+ T cells from a BALB/c mouse were isolated and approximately 50,000
cells were seeded in a U-bottomed 96 well plate. The cells were activated with
10 ng/mL of Phorbol 12-myristate 13-acetate and 0.1 μM Ionomycin. This picture
was taken 36 hours post-activation.
vii
Contents
ix
x Contents
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 295
Chapter 1
Cytokine Receptor Signaling
and CD4/CD8 Lineage Choice during
T Cell Development in the Thymus
1.1 Introduction
T cell immunity is controlled by two major subsets of T cells that can be identified
by their distinct expression of the coreceptor molecules CD4 and CD8. T cells that
express the CD4 coreceptor recognize peptide antigens in the context of MHC class
II molecules and provide helper functions. T cells that express the CD8 coreceptor,
in contrast, react with peptide antigens in the context of MHC class I and exhibit
cytolytic activities [50, 82]. Notably, there is a remarkable correlation between
coreceptor expression and T cell function, such that CD4 coreceptor expression
marks helper lineage T cells, whereas CD8 coreceptor expression is associated
with cytolytic activity. The association between coreceptor phenotype and T effector
function is thought to be imposed during T cell development in the thymus, where
immature thymocytes that express both CD4 and CD8 coreceptor molecules, i.e.,
CD4+ CD8+ double-positive (DP) cells, make lineage decision into either CD4
single-positive (CD4SP) or CD8 single-positive (CD8SP) T cells [8, 28, 88]. The
process of CD4 versus CD8 cell fate decision has fascinated immunologists for a
long time. However, deciphering the molecular basis of this process turned out to
be a daunting task. A major obstacle is the multiplicity of events that occur at the
same time when CD4 versus CD8 lineage commitment is made. Most prominently,
CD4/CD8 lineage choice coincides with the T cell receptor (TCR)-induced positive
selection, which upregulates TCR expression. However, positive selection also
induces changes in coreceptor expression, so that the exact cellular phenotype at
lineage decision had remained obscure and confusing [88].
Because TCR specificity imposes MHC restriction that is further matched with
the appropriate CD4 or CD8 coreceptor expression, classically, CD4/CD8 lineage
choice has been considered a developmental event that is primarily controlled by
TCR signaling [5, 28, 36, 113]. However, TCR signaling alone cannot satisfactorily
explain the entire process of CD4 versus CD8 lineage commitment. In fact, it
became evident that cell fate decision in the thymus requires additional regulatory
pathways, working in concert with TCR signaling to determine the lineage choice.
A series of experimental results followed by further genetic evidence revealed this
requirement to be the signaling by intra-thymic cytokines. Thus, cytokine signaling
activity specifies CD4/CD8 lineage fate during positive selection and further
imposes T cell function and promotes maturation of post-selection thymocytes
[10, 67, 74, 117]. In this article, we aimed to review our current understanding of
CD4/CD8 lineage choice during T cell development and to highlight recent findings
on the role of cytokine receptor signaling in this process.
Because both CD4SP and CD8SP cells originate from DP thymocytes, early
attempts to explain CD4 versus CD8 lineage choice were proposed around the
idea that lineage decision was made by selectively extinguishing the expression of
one or the other coreceptor [23, 103]. The molecular identity of the signals that
would instruct the termination of either CD4 versus CD8 coreceptor expression,
however, remained disputed. Different hypotheses and their variations of stochastic
or instructional mechanisms were put forward to explain the progression of DP into
SP cells [4, 5, 7, 28, 103]. Because forced expression of an MHC class I (MHC-I)
restricted TCR results in the generation of CD8 T cells, but MHC class II (MHC-II)-
restricted TCR transgenes produce CD4 T cells, evidently, lineage fate is encoded
in the specificity of the TCR. However, it was not known how this information was
extracted by the immune system and then translated into lineage specification. An
attractive model that has been favored for a long time proposed that MHC-I- versus
MHC-II-restricted TCRs differ in their signaling strength, such that strong TCR
signals terminate CD8 expression and drive CD4 lineage choice, whereas weak TCR
signals terminate CD4 expression and impose CD8 lineage fate [5, 28, 36, 103].
With regard to the molecular basis of distinct TCR signaling strength, it was noted
that CD4 coreceptors, which preferentially associate with MHC-II-restricted TCR,
binds significantly larger amounts of the tyrosine kinase Lck than CD8 coreceptors,
which associates with MHC-I-specific TCR [97, 99, 100]. Thus, the “strength-of-
signal” model posits that CD4/CD8 lineage choice is made at the DP stage, where
quantitative differences in TCR signals instruct the expression of an MHC-matched
coreceptor that associates with the signal-transducing TCR [5, 36, 37, 56, 108].
1 Cytokine Receptor Signaling and CD4/CD8 Lineage Choice during T Cell. . . 3
Fig. 1.1 The kinetic signaling model of CD4/CD8 lineage decision. Positive selection of immature
DP thymocytes induces the termination of Cd8 coreceptor gene expression that converts DP
cells into transcriptionally Cd4+ Cd8− and phenotyptically CD4+ CD8lo intermediate cells. If the
positive selecting TCR signal persists, such as MHC-II-restricted TCRs that do not depend on
CD8, persistent TCR signals upregulate the expression of the CD4-specifying transcription factor
ThPOK and desensitize cytokine receptors to impose CD4 lineage fate. However, if TCR signaling
ceases, such as for MHC-I-restricted TCRs that require CD8 coreceptor expression, the cessation
of TCR signals permits cytokine receptor signaling. It is then the intra-thymic cytokines that induce
the expression of the CD8 lineage-specifying transcription factor Runx3 which downregulates CD4
transcription, upregulates CD8 expression, and antagonizes ThPOK to seal CD8 lineage fate
4 M. A. Luckey and J. H. Park
Thus, MHC-II-specific TCR signals persist during CD4/CD8 lineage decision, and
persistent TCR signals upregulate the expression of the transcription factor ThPOK
which specifies CD4 lineage choice [32, 90]. TCR signaling further desensitizes
cytokine receptors in positively selected cells that could otherwise signal to induce
the expression of the CD8 lineage-specifying factor Runx3 [24, 67, 74]. By contrast,
the downregulation of CD8 terminates the signaling of MHC-I-specific TCRs, such
that ThPOK expression cannot be induced, and the possibility of CD4 lineage
specification is aborted. Consequently, the kinetic signaling model posits that it is
the kinetics – not the strength – of TCR signaling that determines the CD4 versus
CD8 lineage fate during T cell development in the thymus.
While cessation of TCR signaling abolishes ThPOK upregulation, it was difficult
to explain how the absence of TCR signal would induce Runx3 expression. It is now
known that the cessation of TCR signals is necessary to sensitize cytokine receptors,
and it is cytokine receptor signaling that upregulates Runx3 expression and imposes
CD8 lineage fate [24, 67, 74] (Fig. 1.1). Thus, two distinct signals govern T cell fate
in the thymus; TCR signals drive CD4 helper lineage differentiation, and cytokine
signaling specifies CD8 cytolytic lineage choice.
Cytokine receptor signaling plays a critical role throughout the generation and
maintenance of T cells, and it is especially important for the earliest stages of T cell
development in the thymus. In particular, cytokines of the common γ-chain family
(γc) play a non-redundant role in thymopoiesis, as illustrated in the dramatically
reduced thymocyte numbers and developmental block in γc-deficient mice [11,
20] (Fig. 1.2). The γc cytokine family has six members, namely, IL-2, IL-4, IL-
7, IL-9, IL-15, and IL-21, which all share γc for ligand binding and signaling
[106]. However, the absence of IL-7 or its proprietary receptor IL-7R α-chain
(IL-7Rα) phenocopies γc deficiency, indicating that IL-7 signaling through the IL-
7Rα/γc receptor complex is the molecular basis for the γc requirement during T
cell development [6, 89, 105]. Due to the prominent role of IL-7 in providing
pro-survival signals to lymphocytes [27, 80, 102], early studies to understand the
IL-7 requirement in T cell development heavily focused on the anti-apoptotic role
of IL-7 signals [6, 89, 105]. Such views were further supported by experimental
data reporting significantly improved thymopoiesis upon the introduction of anti-
apoptotic Bcl-2 transgenes into IL-7Rα- or γc-deficient mice [3, 51, 69, 104].
However, careful analysis of immature CD4, CD8 double-negative (DN) thymo-
cytes revealed that the developmental and phenotypic block in γc-deficient mice was
incompletely rescued by forced Bcl-2 expression. While transgenic expression of
Bcl-2 substantially improved the survival and numbers of thymocytes in γc-deficient
Bcl-2-transgenic mice, there was still a dramatic developmental arrest at the DN2
(CD44+ CD25+ ) to DN3 (CD44− CD25+ ) stage of thymocyte differentiation. These
results and other studies indicated that pro-survival signals alone are insufficient to
1 Cytokine Receptor Signaling and CD4/CD8 Lineage Choice during T Cell. . . 5
Fig. 1.2 Cytokine receptor expression during T cell differentiation in the thymus. Cytokine recep-
tor signaling plays critical roles during the early thymocyte development and during CD4/CD8
lineage choice upon positive selection. While most thymocyte subpopulations express copious
amounts of IL-7Rα and γc, immature DP thymocytes are unique as they have terminated IL-7Rα
and have downregulated γc expression, which renders them non-responsive to IL-7 and other pro-
survival cytokines. Understanding the role and contribution of individual γc family members in
CD4/CD8 lineage choice remains an active area of research
TCR receptor. Once functional TCRs are expressed, TCR signals and not cytokine
signals would drive lineage decision of immature DP thymocytes. Consequently,
in conventional models of CD4/CD8 lineage commitment, there is no mechanistic
requirement for cytokine signaling in T cell differentiation [7, 28, 36]. In this
regard, the kinetic signaling model is unique, because it predicts the requirement
of a cellular signal other than TCR signals to induce CD8 and downregulate CD4
expression in uncommitted CD4+ CD8lo cells [10, 61]. Such an idea is inherent
to the kinetic signaling model, because the model posits that TCR signaling is
necessarily terminated in MHC-I engaged cells as the loss of CD8 expression
destabilizes CD8 coreceptor-dependent TCR engagement (Fig. 1.1). Therefore,
TCR signals are unlikely to drive CD8 lineage specification. Instead, CD8 lineage
specification signal was initially proposed to be provided by intra-thymic cytokines,
specifically by IL-7 [10]. This idea was later confirmed in a series of in vivo
animal studies, where IL-7 signaling was specifically terminated in pre-selection
DP thymocytes by the conditional deletion of γc, IL-7Rα, or STAT5a/b expression
[67, 74]. STAT5 is a transcriptional activator that acts downstream of IL-7Rα/γc
and induces the expression of Runx3 [35, 74]. Notably, the absence of STAT5
or IL-7Rα/γc expression did not affect CD4 lineage choice but had profound
effects on CD8 lineage commitment, resulting in a substantial loss (~70%) of
CD8SP thymocyte number and frequency [24, 67, 74]. Differentiation into CD4SP
thymocytes, on the other hand, remained unaffected, illustrating a fundamental
difference in lineage specification signals between CD4 and CD8 T cells.
zation are not fully understood. However, it is known that TCR signaling induces the
destabilization and loss of JAK1 proteins, which interferes with the signaling of γc
family cytokines [41]. TCR signaling was also proposed to cleave the cytosolic tail
of γc by activation of the calcium-activated cysteine protease calpain, which would
debilitate γc cytokine signaling [71].
During thymic lineage differentiation, persistent TCR signals also induce the
expression of the CD4-specifying transcription factor ThPOK [32, 90]. Notably,
ThPOK acts as a transcriptional activator to upregulate the expression of SOCS
molecules, such as SOCS1, SOCS3, and Cish [64]. Because members of the
SOCS family molecules are potent inhibitors of cytokine signaling [115], their
increased abundance by ThPOK curtails cytokine signaling during CD4 lineage
differentiation. In fact, suppression of cytokine signaling is a critical step in CD4
lineage differentiation that was found to be sufficient to restore CD4 lineage
specification in the absence of ThPOK [64].
Upregulation of ThPOK expression is a critical event in CD4/CD8 lineage
choice because ThPOK is both necessary and sufficient to impose CD4 lineage
fate during positive selection [32, 34, 68, 90]. Consequently, ThPOK expression
is tightly controlled during T cell development. ThPOK expression is suppressed in
pre-selection DP thymocytes by the concerted action of the transcription factors
Runx1 and MAZR [83] and requires GATA-3 for its induction during CD4
lineage differentiation [107]. A naturally occurring ThPOK-mutant mouse strain
that expresses non-functional ThPOK proteins is unable to generate CD4 helper T
cells and thus has been referred to as helper deficient (HD) [42]. MHC-II-restricted
thymocytes are positively selected in HD mice, but they fail to commit into CD4
cells and instead undergo lineage redirection into CD8 T cells. Strikingly, enforced
expression of SOCS1 effectively rescued the CD4 T cell-deficiency in HD mice
[64]. Thus, suppression of cytokine signaling could replace the ThPOK requirement
in CD4 lineage specification, resulting in the generation of ThPOK-deficient CD4 T
cells [64]. Such ThPOK-deficient CD4 T cells still exerted helper function, because
they upregulated CD40L expression upon TCR stimulation. These results indicated
that cytokine signaling, or the absence thereof, underpins the basis of CD4/CD8
lineage decision.
In the same vein, while enforced expression of ThPOK redirected MHC class
I-selected thymocytes into CD4 lineage T cells [32, 90], ablation of SOCS1 could
correct lineage choice in ThPOK-transgenic mice, resulting in the re-appearance
of CD8SP thymocytes and mature CD8 T cells [64]. Collectively, these results
revealed that the persistence of positively selected TCR signals is primarily required
to disable cytokine signaling during CD4 lineage differentiation. These findings
agree that it is cytokine signaling which directs CD4/CD8 lineage choice during
T cell development in the thymus.
8 M. A. Luckey and J. H. Park
The molecular basis for a cytokine requirement in CD8 lineage differentiation can be
explained by the fact that CD8 specification is driven by Runx3, whose expression
in turn is induced by cytokine signaling [2, 67, 74]. Runx3 is selectively induced
upon CD8, but not CD4, lineage differentiation and is required to activate the Cd4
silencer and to upregulate CD8 coreceptor expression. These are precisely the two
core events of coreceptor reversal [31, 74, 96], and thus, they place Runx3 as a
central regulator of CD8 T cell lineage fate. Runx3 gene expression is controlled
by two distinct promoter elements, i.e. proximal and distal, and they regulate
Runx3 transcription in a tissue-specific manner. The distal promoter-driven Runx3
(Runx3d) initiates protein translation at the distal exon 1, and it encodes for a Runx3
protein with 19 extra amino acids at the N-terminal end compared to the Runx3
protein produced from the proximal exon 1 [21]. Functional differences between
the Runx3 molecules that are expressed either from the distal versus the proximal
promoter are not known. But, their tissue-specific expression is quite distinct.
Runx3d is specifically expressed in CD8 lineage T cells, whereas the proximal
promoter-driven Runx3 is mostly found in cells outside of the lymphoid system [21,
63]. The precise molecular pathway involved in regulating distal versus proximal
promoter-driven Runx3 expression is not mapped.
CD8 lineage differentiation has been associated with the cessation of TCR
signaling [88]. However, it has not been straightforward to understand how the
loss of TCR signals would induce the upregulation of Runx3 to specify CD8
lineage choice. New insights into this process were recently provided in a study
where the timing and duration of MHC class I-mediated signals were examined
in great detail [47]. The analyses revealed the surprising finding that CD8 lineage
differentiation was achieved in two sequential phases. Phase 1 is triggered by TCR
signaling and results in the gradual loss of CD8 coreceptor expression, concurrent
to the acquisition of cytokine responsiveness. Phase 2, in contrast, is triggered and
driven by cytokine receptor signaling, and it is associated with an incremental
gain of CD8 coreceptor expression, concomitant to a decrease in CD4 coreceptor
abundance. Analysis of Rag2-deficient OT-I TCR transgenic thymocytes further
revealed that Runx3d reporter expression was not induced in MHC-I-signaled
CD4+ CD8lo intermediate cells, unless positively selected TCR signals persisted
long enough to induce surface CCR7 expression [47]. Expression of the chemokine
receptor CCR7 is induced by TCR engagement of cortical thymocytes, and in vitro
studies found it to be upregulated within 48 hours of TCR stimulation [98]. The
duration of phase 1 normally does not exceed 53 hours. and it can be significantly
shortened by weaker TCR signals. Interestingly, the duration of phase 2 inversely
correlated with the length of phase 1, and it ranged between 32 and 79 hours. Thus,
the accelerated progression in phase 2 compensates for any prolonged residency in
phase 1. This mechanism is referred to as “signaling compensation,” and it provides
the molecular basis for the unexpected observation that the duration of positively
1 Cytokine Receptor Signaling and CD4/CD8 Lineage Choice during T Cell. . . 9
selected TCR signals (phase 1) inversely correlates with the time span to undergo
coreceptor reversal (phase 2) [47]. Collectively, these data documented that post-
selection CD4+ CD8lo thymocytes comprise two subsets, where CCR7-negative
CD4+ CD8lo cells are in phase 1 and do not express Runx3d, whereas CCR7-positive
CD4+ CD8lo cells are in phase 2, express Runx3d, and have committed to CD8
lineage fate.
Understanding the molecular mechanism that drives Runx3 expression during
coreceptor reversal is a core issue in CD4/CD8 cell fate decision. Experimental
results strongly advocate for a role of cytokines, and not of TCR signaling, in
inducing Runx3 expression [24, 64, 67, 74]. Specifically, the γc family cytokines
IL-7 and IL-15 are known to be the major players in Runx3 upregulation and
CD8 cell differentiation in the thymus [10, 67, 74]. However, the lack of IL-7
or γc signaling did not completely abolish CD8 cell generation in the thymus
[11, 20, 24, 67, 78, 94, 105], which questioned if all CD8 lineage differentiation
is driven by cytokine signaling. Potential redundancy among cytokines could
provide a potential explanation, but this had not been formally demonstrated.
A recent report addressed this issue [24], and the results provided a definitive
answer to this long-standing question. Accordingly, there is significant redundancy
among γc and non-γc cytokines in inducing Runx3d expression, and the lineage
commitment of all CD8 T cells is dependent on cytokine receptor signaling [24].
Because γc-deficient mice still contain residual CD8SP cells, in that study, a
new genetic model of combined cytokine deficiency was developed that not only
lacked γc but also IL-6, IFNγ, and TSLP signaling and was thus referred to
as “CytoQuad” (γccKO IL-6KO IFNγRKO TSLPRKO ) mice [24]. CytoQuad mice are
severely impaired in generating CD8SP cells, and it is the first in vivo model that
directly demonstrates redundancies among γc and non-γc cytokines in upregulating
Runx3d and imposing CD8 lineage fate. Notably, CytoQuad mice still produced
some CD8 T cells, but they were less than 8% in their frequency compared with
wild-type mice. These residual CD8 cells were presumably generated independently
of JAK-STAT signaling as they appeared in SOCS1-transgenic mice [24]. In-
depth analysis of these few CD8 T cells revealed that these cells were generated
by JAK-STAT-independent TGFβ signaling. Consequently, the genetic deletion of
TGFβR1 in combination with the removal of all γc and non-γc lineage-specifying
cytokines resulted in the complete loss of CD8SP cells. These results unequivocally
established that the development of CD8 T cells is exclusively driven by in vivo
cytokine signaling.
Notably, the CytoQuad mouse also demonstrated that the identity of individual
lineage-specifying cytokines does not matter much, as it is the total amount of
cytokine signals that is critical to confer CD8 lineage fate [24]. All lineage-
specifying cytokines induce Runx3d, and it is likely that MHC-I-selected thymo-
cytes are signaled by multiple intra-thymic cytokines during CD8 cell differen-
tiation. In agreement, all CD8SP thymocytes in wild-type mice express CD103
which is a signature of TGFβ signaling [22], and they also have upregulated Bcl-2,
which is induced by γc cytokines [24, 67], indicating that CD8SP cells normally
receive both cytokine signals. Currently, it remains unclear to which extent each
10 M. A. Luckey and J. H. Park
IL-7 signaling is critical for T cell development in the thymus, but the receptor
for IL-7 is not found on all thymocytes [76], and its expression is developmen-
tally regulated during thymic maturation (Fig. 1.2). The signaling-competent IL-7
receptor is composed of the IL-7-proprietary IL-7Rα chain and the γc, which is
shared with other members of the γc cytokine family [66, 106]. IL-7Rα expression
is required to generate all lymphocytes, including some innate lymphoid cells (ILC),
specifically ILC2 and ILC3 [19]. All lymphocytes express IL-7Rα at some point
during their development, as demonstrated with IL-7Rα fate-mapping mice [84].
However, not all lymphocytes express and maintain IL-7Rα expression throughout
their life. Mechanistically, it is known that the developmental requirement for IL-
7Rα expression differs among cell types. γδ T cells and B cells depend on IL-7R
signaling for their antigen receptor recombination, whereas conventional αβ T
cells require IL-7R signaling for survival and proliferation during early thymic
development [38, 66, 89]. Notably, upon maturation and export into peripheral
tissues, B cells terminate IL-7Rα expression and become independent of IL-7
signaling for their survival. However, T cells remain dependent on IL-7, and they
require intermittent IL-7R signaling for long-term survival and maintenance in the
periphery [46, 85, 93]. Because of its importance in both T cell generation and
maintenance, the molecular mechanisms of IL-7Rα gene expression and regulation
have been extensively investigated. The current literature indicates that IL-7Rα
gene expression is primarily regulated by transcriptional mechanisms. Several
transcription factors positively regulate IL-7Rα expression by acting on either the
promoter or a conserved enhancer region (CNS-1) that is located 3.5-kb upstream of
the transcription initiation site [44, 55]. In addition, transcriptional activators, such
as GABPα, Runx1, FoxO1, and glucocorticoid receptors, induce the expression of
IL-7Rα [12, 21, 44, 73, 111], whereas transcriptional repressors, such as Foxp3,
Foxp1, and Gfi1, suppress IL-7Rα expression [26, 59, 62, 75, 87]. Whether the
CNS-1 enhancer alone would be sufficient to control IL-7Rα gene expression or if
other regulatory elements are involved in these processes has not been clear.
To address this question, IL-7Rα CNS-1-deficient mice were generated and
examined for IL-7Rα expression [1]. Surprisingly, CNS-1-deficient thymocytes
were virtually indistinguishable with respect to their IL-7Rα expression compared
1 Cytokine Receptor Signaling and CD4/CD8 Lineage Choice during T Cell. . . 11
to WT controls, indicating that the CNS-1 activity is not required for IL-7Rα
expression in thymocytes [1]. The developmental stage-specific regulation of IL-
7Rα expression was also unaffected by the absence of CNS-1 because IL-7Rα
was correctly expressed on DN and SP thymocytes and absent on DP cells of
CNS-1-deficient thymocytes. On the other hand, CNS-1 deficiency substantially
diminished IL-7Rα expression and impaired both the IL-7-dependent survival and
proliferation of mature peripheral T cells. Consequently, both CD4 and CD8 naive
T cell numbers were significantly reduced in CNS-1-deficient mice. These results
revealed a developmentally controlled requirement for CNS-1 to upregulate IL-7Rα
expression, such that the CNS-1 enhancer plays a limited role in thymocytes but
is required for IL-7Rα expression in mature T cells [1, 44, 73]. These data further
indicated that regulatory elements other than CNS-1 are involved in controlling IL-
7R expression in thymocytes, but this remains to be tested. Previously, an intronic
site in the Il7r gene was shown to contain a binding site for the transcriptional
repressor Gfi1 that suppresses IL-7Rα expression in CD8 lineage cells [59, 75]. But,
whether this element participates in the thymocyte-specific regulation of IL-7Rα
remains unclear. Additionally, a long-coding RNA known as lnc-IL7R was recently
identified within the sense strand of the 3 untranslated region (3’UTR) of the human
IL-7Rα gene [18]. Lnc-IL7R encodes a 1,427-nucleotide transcript that shares the
poly-A tail with the IL-7Rα gene. It would be interesting to examine if Lnc-IL7R
interferes with IL-7Rα mRNA expression. Collectively, these results demonstrate
the utilization of distinct molecular mechanisms to control IL-7Rα expression in
immature versus mature T cells, and they further illustrate that our understanding of
IL-7Rα regulation is still far from complete.
A major question that remains unanswered is the signaling mechanism that
drives the re-expression of IL-7Rα on post-selection thymocytes. During thymocyte
development, IL-7Rα is highly expressed on immature DN cells but is curiously
terminated upon differentiation into DP cells. In mature T cells, IL-7 signaling
downregulates the transcription and expression of its own receptor [59, 75], so
that the termination of IL-7Rα expression in DP cells might be the consequence
of IL-7 signaling in DN2/3 thymocytes. However, unlike in mature T cells, IL-
7Rα expression on DP thymocytes does not rebound in the absence of IL-7;
thus, the suppressive mechanisms differ between mature T cells and immature DP
thymocytes. Moreover, persistent IL-7Rα expression on DP thymocytes could be
detrimental to T cell differentiation because it would interfere with the selection of a
TCR-dependent immunocompetent repertoire by providing indiscriminate survival
signals to immature thymocytes, regardless of their TCR specificity. Thus, precisely
timed and controlled IL-7Rα expression provides the molecular basis for a variety
of aspects in T cell development and, most prominently, contributes to lineage fate
decision of CD4 versus CD8 T cells.
12 M. A. Luckey and J. H. Park
Fixing CD4/CD8 lineage fate is not the final step in thymic differentiation, and
post-selection CD4SP and CD8SP thymocytes undergo further maturation before
they are exported to peripheral tissues. Indeed, freshly selected SP thymocytes
exhibit a semi-mature phenotype that is characterized by residual expression of
CD24 and having not yet induced expression of the maturation marker Qa-2
(CD24hi Qa-2lo ) [48]. The non-classical MHC-I molecule Qa-2 is commonly used as
a surface marker to identify the most mature thymocytes [101]. Qa-2 acquisition was
previously found to be mediated by Aire+ medullary thymic epithelial cells [57],
and recent studies further refined the underlying mechanism to be driven by intra-
thymic type I IFN signaling [109]. While the physiological role of Qa-2 on mature
thymocytes is yet to be defined, cytokines play a role in the terminal maturation of
thymocytes, as demonstrated by their requirement to upregulate Qa-2.
Maturation of post-selection thymocytes is also accompanied by increased
expression of the chemokine receptor CCR7 and the downregulation of CD69.
Employing these markers, late-stage maturation of post-selection thymocytes,
which are identified by TCRβ+ CCR7+ [98], can be further divided into three
distinct stages. Based on CD69 and MHC-I expression, CD69+ MHCI-I− thymo-
cytes are referred to as semi-mature (SM) cells, CD69+ MHCI-I+ cells as mature
1 (M1) cells, and CD69− MHC-I+ cells as mature 2 (M2) cells [109]. Rag2-
GFP reporter mice revealed a linear relationship among these populations, where
newly selected cells are SM that become M1 and then mature into M2 cells
[109]. Interestingly, maturation of post-selection thymocytes was accompanied by
an increase in IFN-signaling gene signature, such that STAT1 and IRF7 were found
in greater abundance in M1 and M2 cells [109]. Because medullary thymic epithelial
cells constitutively produce IFNβ [58, 72], these results indicated that medullary
thymocytes are exposed to and signaled by type I IFNs and that IFN signaling
would further drive the maturation and differentiation of post-selection thymocytes,
including the acquisition of Qa-2 expression [109].
Along these lines, the migration of positively selected thymocytes into the
medulla is a critical event in thymocyte maturation [25, 70, 92]. Both the negative
selection of auto-reactive thymocytes and generation of Foxp3+ Treg cells require
the thymus medulla [17, 91]. Moreover, the medulla, and particularly the cortico-
medullary junction, is thought to be an important source of intra-thymic cytokines,
such as IL-7 and IL-15 [45, 77]. Importantly, these γc cytokines not only specify
lineage fate but also act as potent pro-survival factors for post-selection thymocytes.
Upon positive selection, the pro-survival pathway of thymocytes is switched
from an RORγt-mediated mechanism, which drives anti-apoptotic Bcl-xL protein
expression, to TCR or cytokine receptor signaling-dependent mechanisms that
upregulate Bcl-2 protein expression [29, 49, 65]. In particular, Bcl-2 is induced in
MHC-II-selected thymocytes by TCR signals, whereas Bcl-2 in MHC-I-selected
thymocytes is upregulated by signaling of cytokines, specifically by cytokines
1 Cytokine Receptor Signaling and CD4/CD8 Lineage Choice during T Cell. . . 13
of the γc family [24]. Notably, it was recently demonstrated that CD8 lineage
specification can be uncoupled from pro-survival signals, so that two distinct classes
of “lineage-specifying cytokines” exist. The non-γc cytokines IL-6, IFNγ, TSLP,
and TGFβ specified CD8 lineage differentiation but lacked pro-survival function.
The γc cytokines IL-7 and IL-15, on the other hand, imposed CD8 cell fate and also
provided pro-survival signals by upregulating Bcl-2 [24, 67]. Thus, intra-thymic γc
cytokines, such as IL-7 and IL-15, are uniquely equipped to maximize CD8 cell
generation, as they not only direct CD8 cell fate but also maintain survival of the
newly generated CD8SP cells. Additionally, cytokines of the γc family can drive
the proliferation of post-selection SP thymocytes, for example, by IL-15, whose
absence results in a significant loss of BrdU incorporation in CD8SP thymocytes
[15], or by IL-21, whose in vivo administration results in a significant expansion
of mature SP thymocytes [79]. Additionally, IL-7 is reported to be required for the
intra-thymic expansion of post-selection thymocytes in neonates [30]. The extent to
which such cytokine-driven expansion of post-selection thymocytes plays a role in
determining the ratio of CD4 versus CD8 thymocytes is an interesting issue that still
needs to be resolved.
the original report, however, it has become clear that IL-7 is not unique in its ability
to direct CD8 lineage fate decision. Instead, certain non-γc cytokines can also direct
CD8 lineage choice, and there is not only some redundancy among γc cytokines but
also a compensatory effect of non γc-cytokines in CD8 cell differentiation [67, 74,
94]. These findings are notable because they can explain the appearance of CD8SP
cells in IL-7Rα- or γc-deficient mice, which still generate Runx3+ CD8SP cells
despite the lack of IL-7 and/or IL-15 signaling [67, 74, 94]. Nonetheless, whether
it is the signaling by other cytokines that can replace IL-7 or IL-15 signaling had
not been formally established. The definitive evidence demonstrating that cytokine
signaling is absolutely required to generate CD8 T cells was only provided with the
availability of CytoQuad mice that additionally lacked TGFβ receptor expression
[24]. In these mice, all lineage-specifying cytokines are absent. Consequently, CD8
T cell generation was completely abolished. These results unequivocally establish
that CD8 lineage commitment is a process that is dependent on cytokine signaling
and thus document an essential role for in vivo cytokines in directing thymocyte
lineage choice.
It remains to be assessed how cytokine signaling is controlled, so that CD4
lineage cells are excluded from lineage-specifying cytokine signals. Moreover, it
is also unclear whether quantitative and qualitative differences in cytokine signaling
produce CD8 cells with distinct function. In this regard, post-commitment IL-4
signaling induces the generation of IFNγ-producing innate-like CD8 T cells [39],
and aberrant IFNγ signaling was previously shown to redirect MHC-II-restricted
thymocytes into CD8 lineage cells [13]. Thus, there is certainly plasticity and some
lineage errors during CD4/CD8 lineage commitment, but these pathways also seem
to involve cytokine signaling. Because the developmental history of T cells in the
thymus is so much entangled with cytokine receptor signaling, it is not surprising to
find the same mechanism to operate T cell differentiation in mature T cells. In fact,
effector T cell differentiation in the periphery mirrors the developmental process in
the thymus which re-emphasizes the importance of understanding the molecular
mechanisms in thymic development to truly understand the differentiation and
effector functions of mature T cells.
Acknowledgments We thank Drs. Changwan Hong (Pusan University), Alfred Singer (NCI,
NIH), and Yousuke Takahama (NCI/NIH) for the critical review and comments. This work was
supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for
Cancer Research.
References
23. Ellmeier W, Sawada S, Littman DR (1999) The regulation of CD4 and CD8 coreceptor gene
expression during T cell development. Annu Rev Immunol 17:523–554
24. Etzensperger R, Kadakia T, Tai X, Alag A, Guinter TI, Egawa T, Erman B, Singer A (2017)
Identification of lineage-specifying cytokines that signal all CD8(+)-cytotoxic-lineage-fate
’decisions’ in the thymus. Nat Immunol 18:1218–1227
25. Feng C, Woodside KJ, Vance BA, El-Khoury D, Canelles M, Lee J, Gress R, Fowlkes BJ,
Shores EW, Love PE (2002) A potential role for CD69 in thymocyte emigration. Int Immunol
14:535–544
26. Feng X, Wang H, Takata H, Day TJ, Willen J, Hu H (2011) Transcription factor Foxp1 exerts
essential cell-intrinsic regulation of the quiescence of naive T cells. Nat Immunol 12:544–550
27. Fry TJ, Mackall CL (2005) The many faces of IL-7: from lymphopoiesis to peripheral T cell
maintenance. J Immunol 174:6571–6576
28. Germain RN (2002) T-cell development and the CD4-CD8 lineage decision. Nat Rev
Immunol 2:309–322
29. Gratiot-Deans J, Merino R, Nunez G, Turka LA (1994) Bcl-2 expression during T-cell devel-
opment: early loss and late return occur at specific stages of commitment to differentiation
and survival. Proc Natl Acad Sci U S A 91:10685–10689
30. Hare KJ, Jenkinson EJ, Anderson G (2000) An essential role for the IL-7 receptor during
intrathymic expansion of the positively selected neonatal T cell repertoire. J Immunol
165:2410–2414
31. Hassan H, Sakaguchi S, Tenno M, Kopf A, Boucheron N, Carpenter AC, Egawa T, Taniuchi
I, Ellmeier W (2011) Cd8 enhancer E8I and Runx factors regulate CD8alpha expression in
activated CD8+ T cells. Proc Natl Acad Sci U S A 108:18330–18335
32. He X, He X, Dave VP, Zhang Y, Hua X, Nicolas E, Xu W, Roe BA, Kappes DJ (2005) The zinc
finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment.
Nature 433:826–833
33. He X, Park K, Kappes DJ (2010) The role of ThPOK in control of CD4/CD8 lineage
commitment. Annu Rev Immunol 28:295–320
34. He X, Park K, Wang H, He X, Zhang Y, Hua X, Li Y, Kappes DJ (2008) CD4-CD8 lineage
commitment is regulated by a silencer element at the ThPOK transcription-factor locus.
Immunity 28:346–358
35. Hennighausen L, Robinson GW (2008) Interpretation of cytokine signaling through the
transcription factors STAT5A and STAT5B. Genes Dev 22:711–721
36. Hernandez-Hoyos G, Sohn SJ, Rothenberg EV, Alberola-Ila J (2000) Lck activity controls
CD4/CD8 T cell lineage commitment. Immunity 12:313–322
37. Hogquist KA (2001) Signal strength in thymic selection and lineage commitment. Curr Opin
Immunol 13:225–231
38. Hong C, Luckey MA, Park JH (2012) Intrathymic IL-7: the where, when, and why of IL-7
signaling during T cell development. Semin Immunol 24:151–158
39. Jameson SC, Lee YJ, Hogquist KA (2015) Innate memory T cells. Adv Immunol 126:173–
213
40. Kasaian MT, Whitters MJ, Carter LL, Lowe LD, Jussif JM, Deng B, Johnson KA, Witek
JS, Senices M, Konz RF et al (2002) IL-21 limits NK cell responses and promotes antigen-
specific T cell activation: a mediator of the transition from innate to adaptive immunity.
Immunity 16:559–569
41. Katz G, Pobezinsky LA, Jeurling S, Shinzawa M, Van Laethem F, Singer A (2014) T cell
receptor stimulation impairs IL-7 receptor signaling by inducing expression of the microRNA
miR-17 to target Janus kinase 1. Sci Signal 7:ra83
42. Keefe R, Dave V, Allman D, Wiest D, Kappes DJ (1999) Regulation of lineage commitment
distinct from positive selection. Science 286:1149–1153
43. Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, Matsuki N, Charrier
K, Sedger L, Willis CR et al (2000) Reversible defects in natural killer and memory CD8 T
cell lineages in interleukin 15-deficient mice. J Exp Med 191:771–780
1 Cytokine Receptor Signaling and CD4/CD8 Lineage Choice during T Cell. . . 17
44. Kerdiles YM, Beisner DR, Tinoco R, Dejean AS, Castrillon DH, DePinho RA, Hedrick SM
(2009) Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and
interleukin 7 receptor. Nat Immunol 10:176–184
45. Kim GY, Hong C, Park JH (2011) Seeing is believing: illuminating the source of in vivo
interleukin-7. Immune network 11(1):10
46. Kimura MY, Pobezinsky LA, Guinter TI, Thomas J, Adams A, Park JH, Tai X, Singer A
(2013) IL-7 signaling must be intermittent, not continuous, during CD8(+) T cell homeostasis
to promote cell survival instead of cell death. Nat Immunol 14:143–151
47. Kimura MY, Thomas J, Tai X, Guinter TI, Shinzawa M, Etzensperger R, Li Z, Love P,
Nakayama T, Singer A (2016) Timing and duration of MHC I positive selection signals are
adjusted in the thymus to prevent lineage errors. Nat Immunol 17:1415–1423
48. Kishimoto H, Sprent J (1997) Negative selection in the thymus includes semimature T cells.
J Exp Med 185:263–271
49. Kisielow P, Miazek A (1995) Positive selection of T cells: rescue from programmed cell death
and differentiation require continual engagement of the T cell receptor. J Exp Med 181:1975–
1984
50. Klein L, Kyewski B, Allen PM, Hogquist KA (2014) Positive and negative selection of the T
cell repertoire: what thymocytes see (and don’t see). Nat Rev Immunol 14:377–391
51. Kondo M, Akashi K, Domen J, Sugamura K, Weissman IL (1997) Bcl-2 rescues T
lymphopoiesis, but not B or NK cell development, in common gamma chain-deficient mice.
Immunity 7:155–162
52. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W (1993) Interleukin-10-deficient mice
develop chronic enterocolitis. Cell 75:263–274
53. Kuhn R, Rajewsky K, Muller W (1991) Generation and analysis of interleukin-4 deficient
mice. Science 254:707–710
54. Kurobe H, Liu C, Ueno T, Saito F, Ohigashi I, Seach N, Arakaki R, Hayashi Y, Kitagawa
T, Lipp M et al (2006) CCR7-dependent cortex-to-medulla migration of positively selected
thymocytes is essential for establishing central tolerance. Immunity 24:165–177
55. Lee HC, Shibata H, Ogawa S, Maki K, Ikuta K (2005) Transcriptional regulation of the mouse
IL-7 receptor alpha promoter by glucocorticoid receptor. J Immunol 174:7800–7806
56. Legname G, Seddon B, Lovatt M, Tomlinson P, Sarner N, Tolaini M, Williams K, Norton T,
Kioussis D, Zamoyska R (2000) Inducible expression of a p56Lck transgene reveals a central
role for Lck in the differentiation of CD4 SP thymocytes. Immunity 12:537–546
57. Li J, Li Y, Yao JY, Jin R, Zhu MZ, Qian XP, Zhang J, Fu YX, Wu L, Zhang Y, Chen WF (2007)
Developmental pathway of CD4+ CD8- medullary thymocytes during mouse ontogeny and its
defect in Aire− /− mice. Proc Natl Acad Sci U S A 104:18175–18180
58. Lienenklaus S, Cornitescu M, Zietara N, Lyszkiewicz M, Gekara N, Jablonska J, Edenhofer
F, Rajewsky K, Bruder D, Hafner M et al (2009) Novel reporter mouse reveals constitutive
and inflammatory expression of IFN-beta in vivo. J Immunol 183:3229–3236
59. Ligons, D.L., Tuncer, C., Linowes, B.A., Akcay, I.M., Kurtulus, S., Deniz, E., Atasever
Arslan, B., Cevik, S.I., Keller, H.R., Luckey, M.A., et al. (2012). CD8 lineage-specific
regulation of interleukin-7 receptor expression by the transcriptional repressor Gfi1. J Biol
Chem 287, 34386–34399
60. Linowes BA, Ligons DL, Nam AS, Hong C, Keller HR, Tai X, Luckey MA, Park JH (2013)
Pim1 permits generation and survival of CD4+ T cells in the absence of gammac cytokine
receptor signaling. Eur J Immunol 43:2283–2294
61. Littman DR (2016) How Thymocytes achieve their fate. J Immunol 196:1983–1984
62. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras
TR, Fazekas de St Groth B et al (2006) CD127 expression inversely correlates with FoxP3
and suppressive function of human CD4+ T reg cells. J Exp Med 203:1701–1711
63. Lotem J, Levanon D, Negreanu V, Bauer O, Hantisteanu S, Dicken J, Groner Y (2017) Runx3
in immunity, inflammation and Cancer. Adv Exp Med Biol 962:369–393
64. Luckey MA, Kimura MY, Waickman AT, Feigenbaum L, Singer A, Park JH (2014) The
transcription factor ThPOK suppresses Runx3 and imposes CD4(+) lineage fate by inducing
the SOCS suppressors of cytokine signaling. Nat Immunol 15:638–645
18 M. A. Luckey and J. H. Park
65. Ma A, Pena JC, Chang B, Margosian E, Davidson L, Alt FW, Thompson CB (1995) Bclx
regulates the survival of double-positive thymocytes. Proc Natl Acad Sci U S A 92:4763–
4767
66. Mazzucchelli R, Durum SK (2007) Interleukin-7 receptor expression: intelligent design. Nat
Rev Immunol 7:144–154
67. McCaughtry TM, Etzensperger R, Alag A, Tai X, Kurtulus S, Park JH, Grinberg A, Love P,
Feigenbaum L, Erman B, Singer A (2012) Conditional deletion of cytokine receptor chains
reveals that IL-7 and IL-15 specify CD8 cytotoxic lineage fate in the thymus. J Exp Med
209:2263–2276
68. Muroi S, Naoe Y, Miyamoto C, Akiyama K, Ikawa T, Masuda K, Kawamoto H, Taniuchi I
(2008) Cascading suppression of transcriptional silencers by ThPOK seals helper T cell fate.
Nat Immunol 9:1113–1121
69. Nakajima H, Leonard WJ (1999) Role of Bcl-2 in alpha beta T cell development in mice
deficient in the common cytokine receptor gamma-chain: the requirement for Bcl-2 differs
depending on the TCR/MHC affinity. J Immunol 162:782–790
70. Nitta T, Nitta S, Lei Y, Lipp M, Takahama Y (2009) CCR7-mediated migration of developing
thymocytes to the medulla is essential for negative selection to tissue-restricted antigens. Proc
Natl Acad Sci U S A 106:17129–17133
71. Noguchi M, Sarin A, Aman MJ, Nakajima H, Shores EW, Henkart PA, Leonard WJ (1997)
Functional cleavage of the common cytokine receptor gamma chain (gammac) by calpain.
Proc Natl Acad Sci U S A 94:11534–11539
72. Otero DC, Baker DP, David M (2013) IRF7-dependent IFN-beta production in response to
RANKL promotes medullary thymic epithelial cell development. J Immunol 190:3289–3298
73. Ouyang W, Beckett O, Flavell RA, Li MO (2009) An essential role of the Forkhead-box
transcription factor Foxo1 in control of T cell homeostasis and tolerance. Immunity 30:358–
371
74. Park JH, Adoro S, Guinter T, Erman B, Alag AS, Catalfamo M, Kimura MY, Cui Y, Lucas
PJ, Gress RE et al (2010) Signaling by intrathymic cytokines, not T cell antigen receptors,
specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells.
Nat Immunol 11:257–264
75. Park JH, Yu Q, Erman B, Appelbaum JS, Montoya-Durango D, Grimes HL, Singer A (2004)
Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel
mechanism for maximizing IL-7-dependent T cell survival. Immunity 21:289–302
76. Park JY, Jo Y, Ko E, Luckey MA, Park YK, Park SH, Park JH, Hong C (2016) Soluble
gammac cytokine receptor suppresses IL-15 signaling and impairs iNKT cell development
in the thymus. Sci Rep 6:36962
77. Park JY, Ligons DL, Park JH (2018) Out-sourcing for trans-presentation: assessing T cell
intrinsic and extrinsic IL-15 expression with Il15 gene reporter mice. Immune network 18:e13
78. Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park
LS, Ziegler SF, Williams DE, Ware CB et al (1994) Early lymphocyte expansion is severely
impaired in interleukin 7 receptor-deficient mice. J Exp Med 180:1955–1960
79. Rafei M, Rouette A, Brochu S, Vanegas JR, Perreault C (2013) Differential effects of gammac
cytokines on postselection differentiation of CD8 thymocytes. Blood 121:107–117
80. Rathmell JC, Farkash EA, Gao W, Thompson CB (2001) IL-7 enhances the survival and
maintains the size of naive T cells. J Immunol 167:6869–6876
81. Rodewald HR, Waskow C, Haller C (2001) Essential requirement for c-kit and common
gamma chain in thymocyte development cannot be overruled by enforced expression of Bcl-2.
J Exp Med 193:1431–1437
82. Rudolph MG, Stanfield RL, Wilson IA (2006) How TCRs bind MHCs, peptides, and
coreceptors. Annu Rev Immunol 24:419–466
83. Sakaguchi S, Hainberger D, Tizian C, Tanaka H, Okuda T, Taniuchi I, Ellmeier W (2015)
MAZR and Runx factors synergistically repress ThPOK during CD8+ T cell lineage
development. J Immunol 195:2879–2887
1 Cytokine Receptor Signaling and CD4/CD8 Lineage Choice during T Cell. . . 19
84. Schlenner SM, Madan V, Busch K, Tietz A, Laufle C, Costa C, Blum C, Fehling HJ, Rodewald
HR (2010) Fate mapping reveals separate origins of T cells and myeloid lineages in the
thymus. Immunity 32:426–436
85. Schluns KS, Kieper WC, Jameson SC, Lefrancois L (2000) Interleukin-7 mediates the
homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 1:426–432
86. Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I (1991) Development and function of T
cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621–624
87. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, Solomon M,
Selby W, Alexander SI, Nanan R et al (2006) Expression of interleukin (IL)-2 and IL-
7 receptors discriminates between human regulatory and activated T cells. J Exp Med
203:1693–1700
88. Singer A, Adoro S, Park JH (2008) Lineage fate and intense debate: myths, models and
mechanisms of CD4- versus CD8-lineage choice. Nat Rev Immunol 8:788–801
89. Sudo T, Nishikawa S, Ohno N, Akiyama N, Tamakoshi M, Yoshida H, Nishikawa S (1993)
Expression and function of the interleukin 7 receptor in murine lymphocytes. Proc Natl Acad
Sci U S A 90:9125–9129
90. Sun G, Liu X, Mercado P, Jenkinson SR, Kypriotou M, Feigenbaum L, Galera P, Bosselut R
(2005) The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic
T cell positive selection. Nat Immunol 6:373–381
91. Takaba H, Takayanagi H (2017) The mechanisms of T cell selection in the Thymus. Trends
Immunol 38:805–816
92. Takahama Y (2006) Journey through the thymus: stromal guides for T-cell development and
selection. Nat Rev Immunol 6:127–135
93. Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, Weinberg KI, Surh CD (2001) IL-7 is critical
for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A 98:8732–
8737
94. Tani-ichi S, Shimba A, Wagatsuma K, Miyachi H, Kitano S, Imai K, Hara T, Ikuta K (2013)
Interleukin-7 receptor controls development and maturation of late stages of thymocyte
subpopulations. Proc Natl Acad Sci U S A 110:612–617
95. Taniuchi I (2018) CD4 helper and CD8 cytotoxic T cell differentiation. Annu Rev Immunol
36:579–601
96. Taniuchi I, Osato M, Egawa T, Sunshine MJ, Bae SC, Komori T, Ito Y, Littman DR (2002)
Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during
T lymphocyte development. Cell 111:621–633
97. Turner JM, Brodsky MH, Irving BA, Levin SD, Perlmutter RM, Littman DR (1990)
Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic
domains of CD4 and CD8 is mediated by cysteine motifs. Cell 60:755–765
98. Ueno T, Saito F, Gray DH, Kuse S, Hieshima K, Nakano H, Kakiuchi T, Lipp M, Boyd RL,
Takahama Y (2004) CCR7 signals are essential for cortex-medulla migration of developing
thymocytes. J Exp Med 200:493–505
99. Van Laethem F, Tikhonova AN, Pobezinsky LA, Tai X, Kimura MY, Le Saout C, Guinter
TI, Adams A, Sharrow SO, Bernhardt G et al (2013) Lck availability during thymic selection
determines the recognition specificity of the T cell repertoire. Cell 154:1326–1341
100. Veillette A, Bookman MA, Horak EM, Bolen JB (1988) The CD4 and CD8 T cell surface
antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell
55:301–308
101. Vernachio J, Li M, Donnenberg AD, Soloski MJ (1989) Qa-2 expression in the adult murine
thymus. A unique marker for a mature thymic subset. J Immunol 142:48–56
102. Vivien L, Benoist C, Mathis D (2001) T lymphocytes need IL-7 but not IL-4 or IL-6 to survive
in vivo. Int Immunol 13:763–768
103. von Boehmer H (2000) T-cell lineage fate: instructed by receptor signals? Curr Biol 10:R642–
R645
104. von Freeden-Jeffry U, Solvason N, Howard M, Murray R (1997) The earliest T lineage-
committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression.
Immunity 7:147–154
20 M. A. Luckey and J. H. Park
105. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R (1995)
Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant
cytokine. J Exp Med 181:1519–1526
106. Waickman AT, Park JY, Park JH (2016) The common gamma-chain cytokine receptor: tricks-
and-treats for T cells. Cell Mol Life Sci 73:253–269
107. Wang L, Wildt KF, Zhu J, Zhang X, Feigenbaum L, Tessarollo L, Paul WE, Fowlkes BJ,
Bosselut R (2008) Distinct functions for the transcription factors GATA-3 and ThPOK during
intrathymic differentiation of CD4(+) T cells. Nat Immunol 9:1122–1130
108. Watanabe N, Arase H, Onodera M, Ohashi PS, Saito T (2000) The quantity of TCR signal
determines positive selection and lineage commitment of T cells. J Immunol 165:6252–6261
109. Xing Y, Wang X, Jameson SC, Hogquist KA (2016) Late stages of T cell maturation in the
thymus involve NF-kappaB and tonic type I interferon signaling. Nat Immunol 17:565–573
110. Xiong Y, Bosselut R (2012) CD4-CD8 differentiation in the thymus: connecting circuits and
building memories. Curr Opin Immunol 24:139–145
111. Xue HH, Bollenbacher J, Rovella V, Tripuraneni R, Du YB, Liu CY, Williams A, McCoy
JP, Leonard WJ (2004) GA binding protein regulates interleukin 7 receptor alpha-chain gene
expression in T cells. Nat Immunol 5:1036–1044
112. Yamane H, Paul WE (2012) Cytokines of the gamma(c) family control CD4+ T cell
differentiation and function. Nat Immunol 13:1037–1044
113. Yasutomo K, Doyle C, Miele L, Fuchs C, Germain RN (2000) The duration of antigen
receptor signalling determines CD4+ versus CD8+ T-cell lineage fate. Nature 404:506–510
114. Yin X, Ladi E, Chan SW, Li O, Killeen N, Kappes DJ, Robey EA (2007) CCR7 expression
in developing thymocytes is linked to the CD4 versus CD8 lineage decision. J Immunol
179:7358–7364
115. Yoshimura A, Ito M, Chikuma S, Akanuma T, Nakatsukasa H (2018) Negative regulation of
cytokine Signaling in immunity. Cold Spring Harb Perspect Biol 10
116. Yoshimura A, Naka T, Kubo M (2007) SOCS proteins, cytokine signalling and immune
regulation. Nat Rev Immunol 7:454–465
117. Yu Q, Erman B, Bhandoola A, Sharrow SO, Singer A (2003) In vitro evidence that
cytokine receptor signals are required for differentiation of double positive thymocytes into
functionally mature CD8+ T cells. J Exp Med 197:475–487
118. Yu Q, Park JH, Doan LL, Erman B, Feigenbaum L, Singer A (2006) Cytokine signal
transduction is suppressed in preselection double-positive thymocytes and restored by positive
selection. J Exp Med 203:165–175
119. Zhu J, Paul WE (2010) Peripheral CD4+ T-cell differentiation regulated by networks of
cytokines and transcription factors. Immunol Rev 238:247–262
Chapter 2
An Agent-Based Model of T Helper Cell
Fate Decisions in the Thymus
2.1 Introduction
S. Khailaie
Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology,
Helmholtz Centre for Infection Research, Braunschweig, Germany
Centre for Individualised Infection Medicine, Hannover, Germany
P. A. Robert
Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology,
Helmholtz Centre for Infection Research, Braunschweig, Germany
M. Meyer-Hermann ()
Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology,
Helmholtz Centre for Infection Research, Braunschweig, Germany
Centre for Individualised Infection Medicine, Hannover, Germany
Institute for Biochemistry, Biotechnology and Bioinformatics, Technische Universität
Braunschweig, Braunschweig, Germany
e-mail: mmh@theoretical-biology.de
which could potentially recognize all pathogens present in nature. Consequently, the
acquisition of such new and random receptors allows the adaptive immune system
to be prepared for future and unknown challenges.
The initial repertoire carried by T cell progenitors has the harmful potential
to induce auto-immunity by the later recognition of protein fragments from the
host (self-peptides). It is therefore necessary that the T cell repertoire is shaped to
efficiently react to harmful pathogens (bacteria, viruses, parasites, and altered-self
such as cancer cells) while tolerating healthy tissues at the same time. This tolerance
is achieved in the thymus through a process called thymic selection.
After they express a properly recombined TCR, thymocytes sequentially
encounter various antigen presenting cells (APCs) each expressing diverse self-
peptides on their plasma membrane. Thanks to specific antigen presentation
mechanisms in the thymus, APCs present a large set of self-peptides (but not all) on
their MHC molecules. These self-peptides correspond to a subset of the proteins’
fragments of the individual healthy tissues. It is believed that thymocyte-APC
encounters and the quality of self-antigen recognition is the primary determinant of
cell fate decision in the thymus, namely, cell maturation and differentiation or cell
death [1, 2]. Thymocytes that complete the maturation steps leave the thymus as
major cell types of CD8+ cytotoxic T lymphocyte (CTLs) and CD4+ Tconvs which
contribute to the pro-inflammatory immune response or CD4+ CD25+ Foxp3+ Tregs
that suppress the immune response.
Here, we present the designing steps of an agent-based model for thymic selec-
tion, previously published in [3], which is suitable enough to result in the complex
emerging properties of thymic selection from simple mechanistic hypotheses. The
model provides a straightforward representation of signal processing by thymocytes
into their fate decision, in the thymus.
Fig. 2.1 Affinity, avidity and abundance of ligands. Affinity is a measure for the strength of
interaction between a TCR and a single peptide-MHC complex. The collective strength of
simultaneous binding of the identical TCR molecules on a single T cell to multiple peptide-MHC
complexes on the interacting APC is called avidity. Abundance of a self-peptide indicates the
fraction of thymic APCs that express the self-peptide
Fig. 2.2 Affinity/avidity model of thymic selection. (a) Most thymocytes (≈90% of pre-selection
cells) express TCRs that bind spMHCs too weakly, do not receive a survival signal and further
die by neglect (grey cells). Low affinity interactions of TCRs with spMHCs rescue cells from
death (blue cells), whereas high-affinity interactions induces cell death (red cells). Positively
selected thymocytes undergo cell maturation and migrate out of the thymus to enter the peripheral
T cell pool. (b) Modified affinity model of thymic selection. nTreg selection occurs within an
affinity-window between positive selection and negative selection thresholds. The boundaries of
this window can be subjected to stochastic influences. For example, in TCR-transgenic systems,
expression of a high affinity ligand may induce either nTreg or Tconv selection, or nTreg selection
and clonal deletion. Therefore, a broad range of affinities seems to be permissive for nTreg
differentiation, and the same TCRs can raise both nTreg and Tconv decisions [6]
(see Fig. 2.2a). According to this model, minimum affinity/avidity interactions are
required during positive selection for maturation of thymocytes and protection
against cell death. In contrast, during negative selection (also known as clonal
deletion), thymocytes that encounter high affinity/avidity interactions undergo
apoptosis (cell death) [5, 6]. The affinity model in its classical form does not state
how nTregs are selected.
24 S. Khailaie et al.
TCR-transgenic mouse models were extensively used for studying thymic selection.
In these genetically engineered mice, all thymocytes express copies of an identical
αβ TCR, with the known specificity of the peptides inducing a high affinity. By
manipulating the antigen presentation in the thymus and by the expression of a
ligand with known TCR affinity via a second transgene, the role of affinity/avidity
in thymic selection has been investigated from different angles.
These studies showed that high-affinity interactions deviate clonal deletion to
nTreg differentiation, suggesting that nTregs would arise from thymocytes with
autoreactive (self-reactive) TCRs. It favors an improved version of the affinity
model in which nTreg selection occurs within an affinity-window between positive
selection and negative selection (Fig. 2.2b) [6].
Using an agent-based model of thymic selection [3], we show the outcome of
cell fate determination based on the integrated TCR signal over a sequence of
thymocyte-APC interactions. In the proposed model, not only the affinity/avidity of
interactions contribute to the fate decision, but the single cell history of self-peptide
encounters, and therefore the abundance of presented self-peptides.
2.2 Model
The model consists of agents (cells) each carrying a different, randomly generated
TCR, and aims at investigating which TCR sequences lead to which cell fate
decision. It requires to choose a representation of TCR, peptides, and MHC
sequences and to further derive the affinity between each TCR-pMHC interactions.
In this section, we try to make biologically relevant assumptions to incorporate such
properties in the model.
Structural models for protein interactions are still far away from predicting the
affinity of any two interacting proteins in a reasonable time, that could be used at the
scale of several millions of cells going through thymic selection. Several simplified
representations of affinities of interactions have already been used in literature, such
as [7] in the context of B cells and antibodies. Probabilistic models take abstraction
of the sequences and derive affinities randomly from a distribution function [8, 9].
Each cell would get an average affinity for the pool of pMHC sequences. These
representations are quite limited for thymic selection because they do not take into
account sequence similarities between self-peptides or between TCRs and limit
the analysis of the output cells from thymic selection: which self-peptides do they
2 An Agent-Based Model of T Helper Cell Fate Decisions in the Thymus 25
recognize? which self-peptides drove their selection or death? Here, we use binary
sequences as simplified structural representations of proteins [10–13]. They allow
representing a large diversity of TCR sequences and can be linked with an affinity
function that incorporates the critical properties of protein-protein interaction, such
as the synergy between neighboring interacting amino acids (domains) and the
capacity of similar sequences to have a similar affinity property.
Assume that the interaction interface of each of two interacting proteins (binding
regions) are represented by binary sequences X and Y , both with length L,
X = {xi }L
i=1 , Y = {yi }i=1 with xi , yi ∈ {0, 1}.
L
(2.1)
The following approach is used to calculate the affinity between two proteins.
The “matching sites” of two proteins are the sub-sequences of X and Y which are
complementing each other (opposite value). A binary sequence of matching sites,
called “Complementarity sequence” C, is defined as
1 xi = yi
C(X, Y ) = X ⊕ Y = {ci }L
i=1 with ci = . (2.2)
0 xi = yi
If such single point sites are adjacent to each other, they form matching sites and
therefore contribute more to the global affinity than other sparse and small matching
points. We list the lengths of consecutive 1s that exist in the complementarity
sequence C in another sequence named “Adjacency Matching Sites (AMS)”,
denoted by M(C), in the following way (shown by example in Fig. 2.3):
Here, pj and qj are the locations of the first and last 1s in j -th AMS. The global
affinity (A) of the interaction is defined as the sum of the sizes of the AMS raised to
power r, normalized to the maximum possible value,
r
j (mj )
A(X, Y ) = , (2.4)
Lr
The specificity parameter (r) allows tuning the relative contribution of the largest
AMS into the global affinity. This dependency is illustrated in Fig. 2.3. By increasing
the value of r, the dependency of the affinity to the largest AMS increases, which
results in a high sensitivity of affinity to a single bit alteration in this region of the
sequence and a dramatic decrease in the interaction affinity. Such a dependency
to single point mutations (key mutations) has also been observed experimentally
[14]. Note that the affinity A is not linked to the physiochemical properties of
protein-protein interactions (such as on-rate, off-rate, or dissociation constant) and
26 S. Khailaie et al.
Fig. 2.3 Interaction affinity and signal integration [3]. The affinity between peptide-MHC
complexes and TCRs, both represented as binary sequences, is calculated by obtaining the
complementarity sequence of the two sequences (Ci (TCR, pMHCi ), see Eq. (2.2))/Algorithm (1),
and the adjacency matching sites (Mi (Ci ) – see Eq. (2.3)). The affinity depends on the grouping
effect of adjacency matches (Ai (TCR, pMHCi ) – see Eq. (2.4)). In the illustrated example,
according to Eq. (2.4), the contribution of the largest adjacency match to the affinity is 37.5%
with r = 1. This contribution increases to 71% with r = 3. A bit mutation in the center of the
largest adjacency match region decreases the affinity approximately by 12.5% and 66% with r = 1
and r = 3, respectively. See Table 2.1 for the simulation values
is only a measure of how well the binary sequence representations of proteins are
complementing each other. Therefore, the dimension of affinity A is arbitrary. The
algorithm to calculate the affinity of two binary sequences is given in Algorithm 1.
Algorithm 1 Affinity calculation of two binary sequences
1: procedure AFFINITY(Sequence X, Sequence Y, specificity r)
2: s ←− 0 Length of the current matching
3: sum ←− 0 Will be the accumulated affinity
4: L ←− length of X (and Y)
5: for i from 0 to L-1 do
6: if X[i] = Y [i] then
7: s ←− s + 1
8: else
9: sum ←− sum + s r Matching contributions added at their ending
10: s ←− 0
11: end if
12: end for
13: sum ←− sum + s r
14: Return sumLr
15: end procedure
2 An Agent-Based Model of T Helper Cell Fate Decisions in the Thymus 27
The interaction between a TCR and a peptide-MHC complex occur through well-
defined domains. On the TCR side, these domains are called complementarity
regions (CDR1/2/3). The middle of the binding interface (CDR3) makes contact
with the peptide and the MHC. CDR1/2 loops surround the central CDR3-peptide
region and are in contact with the top of MHC helices [15–17]. While CDR1 and
CDR2 are mostly conserved, the CDR3 loop is a hypervariable element of the TCR
which mediates a major part of the interaction between MHC and TCR. The variable
part of the TCR binds to both the peptide and the borders of MHC surrounding the
peptide. Since the conserved part of TCR interacting with MHC would contribute
equally to each TCR-pMHC interaction, it is not considered in the model.
We assume that the binary sequences representing TCR and pMHC proteins
are aligned and the middle part of the TCR sequence with length Lp contacts the
peptide sequence, and the sides of the TCR sequence (each with length LMHC /2)
contact the MHC sequence. This is illustrated in Fig. 2.3. The affinity of TCR-
pMHC interaction is computed using Eq. (2.4),
We obtain the TCR affinity to a MHC by considering the MHC binary sequence
without the loaded peptide and the corresponding part of the TCR binary sequence,
Two main questions are ignored by the affinity model. First, how can a T cell
perceive information about the affinity of its TCR toward the MHC molecules
versus the self-peptides it encounters? Second, how is the abundance of self-
peptides shaping the repertoire of selected cells of each subset (Tconv and Treg),
knowing that a T cell cannot scan all APCs in the thymus? To accurately explain
the biological properties of thymic selection, namely, the elimination of thymocytes
with low affinity to MHC or self-reactive thymocytes, a temporal integration of the
perceived signal by thymocytes has to be incorporated.
Fig. 2.4 Serial encounter. Thymocytes continuously scan the thymic environment and interact
with thymic APCs each expressing a different subset of the diverse spMHCs pool. Depending
on the number of APCs, thymocytes may compete for interaction with APCs. Depending on the
affinity/avidity of TCR to presented spMHCs and the number of available APCs, integrated signal
fluctuates over time. Integrated signals contain the TCR stimulation history. The extent of this
history depends on how fast integrated signals decay over time
Ai during thymocyte − APC interaction
pi (t) = (2.8)
0 no thymocyte − APC interaction
nspMHC
v(t) = pi (t) (2.9)
i=1
The integrated TCR signal S(t) (ITS) is then updated according to all TCR-
pMHC ligation events following the formula:
dS(t)
= αv(t) − δS(t) (2.10)
dt
where α is the integration rate (with dimension 1/time) and δ is the degradation
rate (with dimension 1/time) of TCR-mediated intracellular signals. The value of α
sets the scale of the signaling and does not influence the qualitative interpretation
of our results. The value of δ sets the extent of memory of the ITS, i.e., how many
past encounters are integrated in the value of ITS at any given time. To investigate
the information encoded into ITS from the limited past encounters, we assumed a
sufficiently high value for δ. The qualitative interpretation of the results are not valid
for a very low value of δ.
Since foreign peptides are not normally presented by thymic resident APCs, the
ITS of thymocytes will implicitly contain information about the level of TCR self-
reactivity. Now, the question is to understand how the ITS encodes self-reactivity
of the carried TCR toward the self-peptides and MHC molecules presented in the
thymus.
30 S. Khailaie et al.
which shall become sufficiently small. It has been estimated that each APC may
present ≈1% of all self-peptides (see [3]). Using the parameter values in Table 2.1,
we assumed that each APC is expressing 2% of all different self-peptides.
According to Eq. (2.11), when we decrease the diversity of self-peptides while
keeping the total number of ligands (spMHCs) presented per APC in the thymus
(nAPC and nspMHC and consequently nAPC × nspMHC ), the abundance of each self-
peptide increases (see Fig. 2.1 for definition of abundance of a ligand).
than the number of APCs (nT ≤ nAPC ), thymocytes do not compete for interacting
with APCs. Therefore, the number of thymocytes (nT ) does not need to represent
a physiological number but rather is chosen according to the desired statistical
significance. In contrast, when the number of APCs is smaller than the number
of thymocytes (nT > nAPC ), thymocytes compete for interacting with APCs at
any given time and with a uniform probability, and a subset of thymocytes remains
without interaction at each time-step. For simplicity and focusing on the impact of
TCR specificity to self-peptides on the ITS, the results are given in the absence of
competition for interacting APCs. The impact of APC availability on the results is
given and discussed in [3]. The parameters used in the presented results are given in
Table 2.1.
Herein, after a simulation with parameter values given in Table 2.1, we checked
the temporal properties of TCR signaling on the scale of single cell. In Fig. 2.5,
some typical ITS curves are shown. As it can be seen in this figure, ITS generally
shows fluctuations. However, due to repeated interactions with APCs and affinity
contribution from the MHC which presents a mixture of self-peptides, the signal
never goes to zero. In addition to steady fluctuations, strong signaling peaks in
ITS can be observed. By recalling the fact that all the APCs carry identical MHCs
in the simulation, one possible reason for strong peaks could be the encounter of
cell with high affinity peptides; another possibility would be the encounter of cells
with multiple peptides with moderate affinities presented by a single APC, which
32 S. Khailaie et al.
Fig. 2.5 Integrated TCR signal (ITS) and fate mapping. (a) Dynamic changes of integrated
TCR signal of two different thymocytes are shown schematically. Sequential interactions of a
thymocyte with APCs which are presenting diverse spMHCs results in fluctuations of the integrated
TCR signal. Within a window of sequential interactions, the sustained signaling level (SSL) is
defined as the minimum value of the ITS. The maximum ITS value in the same window of
interactions is defined as the transient signaling level (TSL). The values of SSL and TSL for each
thymocyte depend on the specificity of their TCRs to encountered spMHCs. (b) SSL and TSL of
all thymocytes are plotted against each other as a scatter diagram. SSL- and TSL-based rules for
thymic selections are estimated and shown
In the presented study, we focus on the selection of CD4+ , and our aim is to
incorporate a signal-based nTreg fate commitment; however, the previous defini-
tions apply for both contexts of CD4+ and CD8+ T cell development. Various
experimental evidence has shown that selection of nTregs in the thymus depends
on interaction of MHC class II-restricted TCRs with high affinity/avidity ligands
[34–38]. Therefore, it is believed that nTreg commitment happens to cells that
express self-reactive TCRs [39] and, therefore, perceive stronger TCR signals than
their Tconv progenitor counterpart [40]. Further, it has been suggested that nTregs
originate from thymocytes expressing TCRs with self-peptide affinities/avidities
that lie between the affinities/avidities thresholds that drive positive and negative
selection [4, 41, 42].
The ability of nTregs to sustain high strength TCR signals is not only required
for nTreg differentiation but also for their homeostasis and functionality in the
periphery [43]. In the context of our model, we assume that the selection of nTregs
requires a sufficiently high SSL. We consider an SSL-threshold for nTreg selection
after which only 5% of the selected repertoire can be selected as nTreg phenotype
(physiological value: 5–10% of total peripheral CD4+ T cells [44] or 4–6% of total
CD4+ thymocytes in mice [45]) (Fig. 2.5b). The percentage values assumed for
thymic output are used to determine the SSL- and TSL-thresholds of positive and
negative selections in the model retrospectively.
TCR signal, are obtained for all thymocytes after an initial stabilizing time. The
distribution of SSL for thymocytes with identical MHC affinity is shown for all
possible MHC affinities in Fig. 2.7a. It is evident that MHC affinity and SSL
are positively correlated, meaning that thymocytes with higher affinity to MHC
sequence
√ have higher SSL (Pearson correlation coefficient p between SSL and
r
A(TCR, MHC) is ≈0.79). This correlation does not exist in a similar extent
between TSL and MHC affinity (data not shown, p ≈ 0.55). A similar analysis
between TSL and the maximum affinity to thymic ligands for all thymocytes reveals
a positive correlation (see Fig. 2.7b, p ≈ 0.75), which is not present at similar
extent between TSL and MHC affinity (data not shown, p ≈ 0.39). These results
suggest that the information about the affinity of TCRs to the selecting MHC and
their cognate spMHC are encoded into different dynamical components of the
integrated TCR signal. This is mainly possible due to the existence of diverse and
low-abundance self-peptides. Decreasing the self-peptide diversity as well as the
number of available APCs destroy the correlation between TCR affinities and the
signaling components (data not shown, see [3]).
Algorithm 2 Main simulation steps for thymic selection
1: procedure THYMIC SELECTION(All parameters)
2: mhc ←− a random binary sequence (size LMH C )
3: peptideSet ←− [] the pool of self-peptides
4: while size(peptideSet) < NSP
5: newP ep ←− random binary sequence (size LP )
6: if newP ep ∈
/ peptideSet then
7: peptideSet ←− peptideSet ∪ newP ep
8: end if
9: end while
10: Initiation of peptide presentation
11: AP C− list ←− []
2 An Agent-Based Model of T Helper Cell Fate Decisions in the Thymus 35
It has been suggested that regulatory T cells might be selected due to high specificity
to self-peptides. To check this, we derived the distribution of affinities to self-
peptides for each TCR and for all the TCR sequences in the preselection, Tconv,
and Treg repertoires (Fig. 2.8a). It is evident that the initial distribution of affinities
is preserved in both Tconv and Treg repertoires.
Another way to measure the effect of thymic selections on the affinity of
thymocytes to self-peptides is to obtain the fraction of thymocytes that recognize
a self-peptide with a certain affinity. Figure 2.8b shows the average of such measure
for all self-peptides. It is evident that the initial distribution is preserved in Treg and
Tconv repertoires.
(A) (B)
Fig. 2.7 Distributions of SSL and TSL; previously published in [3]. (a) Distributions of SSL for
thymocytes with similar MHC affinity shown for all MHC affinity spectrum. (b) The maximum
affinity of each thymocyte to the spMHCs pool is obtained. The distributions of TSL for
thymocytes with identical maximum spMHC affinity is shown for all affinity spectrum. The SSL
is positively correlated with MHC affinity while TSL is positively correlated with the maximum
spMHC affinity. Since proteins are represented by binary sequences, only a finite set of MHC and
spMHC affinities are possible. The thymocytes with close affinity values are grouped. This applies
to all subsequent figures
2 An Agent-Based Model of T Helper Cell Fate Decisions in the Thymus 37
(A) (B)
(C) (D)
Fig. 2.8 Distributions of self-peptide and spMHC affinity. (a) For each thymocyte, the affinity
to all self-peptides is calculated and the affinity distribution is obtained over all thymocytes. (b)
For each self-peptide, the number of thymocytes with different binding affinity is obtained and
averaged over all self-peptides in the pool. (c, d) Similar analysis as of (a, b) for spMHCs in the
pool
A similar analysis for spMHCs (but not self-peptides alone) shows that the initial
distribution is not preserved after thymic selection (see Fig. 2.8c, d). Treg and Tconv
repertoires contain TCRs that recognize thymic ligands with higher affinity, or
in other words, thymic selection eliminates TCRs with low affinity to thymically
expressed spMHCs.